https://www.selleckchem.com/products/arn-509.html
Introduction Recent trials using cannabidiol (CBD) have shown that most acute and prolonged adverse effects of CBD are mild to moderate, with rare serious adverse effects (SAEs). This review focused on analyzing SAEs of CBD and their possible relation to drug-drug interactions.Areas covered We systematically analyzed the SAEs reported in randomized controlled trials (RCTs) involving the administration of oral CBD for at least one week in both healthy volunteers and clinical samples.Expert opinion SAEs related to CBD in RCT are rare and
Like
Comment
Share
